Omada Health Inc (OMDA) Stock Price, Quote & News

Company Profile

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtu...

Industry: Health Information Services

Sector: Healthcare

Phone: 888 987 8337

Website: www.omadahealth.com

Address:

611 Gateway Blvd, Suite 120, South San Francisco, United States

Stocktwits Aug. 18 at 8:28 PM

$OMDA Only 440 watchers here 👀

0 · Reply

upsidetrader Aug. 18 at 7:31 PM

$OMDA Monster bull flagpole followed by a bull flag, earnings were excellent. You could do worse. Holding s/t rising moving averages.

0 · Reply

WhatsTheNext10x Aug. 11 at 12:06 PM

$OMDA Closed above the trend line from the all time highs. Interesting to see what this does today since it’s already made a big move in a short period of time. The funny thing is, the more this is able to rally without pulling back, the stronger the signs that this is just the start of big run up.

0 · Reply

WhatsTheNext10x Aug. 9 at 5:39 AM

$OMDA $ALAB operates in a completely different sector but IPOs act pretty similar. OMDA has a very similar look to how ALAB looks back in 2024 at the start of its amazing run. I’d be more confident if there’s a bit range breakout and close on big volume above its IPO high. No predictions. Will respect what price tells.

0 · Reply

EquityVoyager_1 Aug. 8 at 3:09 PM

$OMDA finally getting the attention it deserves. A strong move after Thursday’s Q2 results - and honestly, the reaction feels overdue. The market still seems to be largely ignoring this name, but the execution continues to impress. Strong results Consistent execution Growing investor attention I just published my full $OMDA review, and as a shareholder, I’m very happy with what I’m seeing. Sometimes the best setups are the ones nobody is talking about yet. And yes - every article I’ve written on $OMDA is completely free to read. If you would like to learn more about marketing strategies, please visit my personal webpage.

0 · Reply

AlphaResearchHQ Aug. 7 at 2:27 PM

$OMDA is one I’m keeping on my radar. The chart is starting to get interesting here. I’m watching the current structure closely because I think we could see a Wave B bounce before another possible flush lower to complete Wave 4. The main level I care about is around $17 support. That’s where I’d be more interested in looking for a setup rather than chasing a move after it already runs. If buyers step in and the pattern confirms, the Wave 5 target could create a much bigger move. Nothing is guaranteed in this market, so I’m letting price action confirm the idea first. Levels matter more than predictions. Want to know the levels I’m watching before considering an entry? I’ll break down the key areas.

0 · Reply

EarningsInsider Aug. 6 at 9:46 PM

https://www.marketbeat.com/earnings/reports/2026-8-6-omada-health-inc-stock/ $OMDA Omada Health Earnings Transcript

0 · Reply

MarketIntel_ Aug. 6 at 9:23 PM

$OMDA Q2 earnings are in, and the numbers came in stronger than expected. Revenue reached $87.8M vs $80.1M estimate, while adjusted EBITDA came in at $10.8M vs $3.5M expected. GAAP EPS turned positive at $0.09 vs $(0.02) estimate. Membership growth remains a key driver with total members reaching 1.091M, up 45% YoY. Management also raised 2026 guidance: Revenue now expected at $334M-$340M vs $328M prior estimate. Adjusted EBITDA guided to $21M.X-$27M vs $17.8M. Growth is accelerating, and the market is starting to notice.

0 · Reply

StocktwitsEarnings Aug. 6 at 8:11 PM

$OMDA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.09 up 137.50% YoY • Reported revenue of $87.83M up 43.12% YoY • For the year ending December 31, 2026, Omada Health expects revenue in the range of $334 million to $340 million and adjusted EBITDA in the range of $21 million to $27 million.

0 · Reply

IN0V8 Aug. 3 at 4:31 PM

$OMDA Barclays raises target price to $25 from $20

0 · Reply

Omada Health price target raised to $25 from $15 at Baird

2026-08-16T13:53:15.000Z - 3 days ago

Omada Health price target raised to $32 from $27 at Citizens

2026-08-16T13:38:49.000Z - 3 days ago

Omada Health price target raised to $30 from $26 at JPMorgan

Aug 11, 2026, 8:00 AM EDT - 8 days ago

Omada Health Transcript: Canaccord Genuity's 46th Annual Growth Conference

2026-08-10T11:35:36.000Z - 9 days ago

Omada Health price target raised to $35 from $30 at BTIG

2026-08-07T14:00:42.000Z - 12 days ago

Omada Health guidance ‘could raise questions,’ says Canaccord

2026-08-07T11:55:26.000Z - 12 days ago

Omada Health price target raised to $24 from $18 at BMO Capital

2026-08-06T21:07:23.000Z - 12 days ago

Omada Health reports Q2 EPS 8c, consensus 6c

2026-08-06T21:06:35.000Z - 12 days ago

Omada Health raises FY26 revenue guidance to $334M-$340M from $322M-$330M

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Omada Health Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Omada Health Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Omada Health Slides: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Omada Health Quarterly report: Q2 2026

Aug 6, 2026, 4:03 PM EDT - 12 days ago

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

2026-08-03T09:45:32.000Z - 16 days ago

Omada Health price target raised to $25 from $20 at Barclays

Jul 23, 2026, 11:27 AM EDT - 26 days ago

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

Jul 23, 2026, 9:00 AM EDT - 27 days ago

Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

2026-07-21T10:55:22.000Z - 4 weeks ago

Omada Health price target raised to $28 from $24 at Canaccord

2026-07-20T09:51:31.000Z - 4 weeks ago

Omada Health price target raised to $27 from $21 at Citizens

2026-07-17T09:40:18.000Z - 4 weeks ago

Omada Health initiated with a Buy at BTIG

Jul 15, 2026, 9:00 AM EDT - 5 weeks ago

Omada Health to Host its First Investor Day on September 10, 2026

2026-07-14T13:55:28.000Z - 5 weeks ago

Omada Health app download growth decelerated in Q2, says Morgan Stanley

Jul 13, 2026, 9:00 AM EDT - 5 weeks ago

Omada Health to Participate in Canaccord Genuity's 46th Annual Growth Conference

2026-06-22T12:59:31.000Z - 2 months ago

Omada Health has ‘catch up potential,’ says Morgan Stanley

HNGE

Jun 16, 2026, 12:00 PM EDT - 2 months ago

Omada Health Transcript: AGM 2026

Jun 10, 2026, 11:20 AM EDT - 2 months ago

Omada Health Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

May 27, 2026, 9:00 AM EDT - 3 months ago

Omada Health to Participate in Goldman Sachs Global Healthcare Conference

2026-05-20T13:18:58.000Z - 3 months ago

3 Small-Cap Stocks with ‘Strong Buy’ Ratings and Big Upside in 2026

MP NSSC

2026-05-08T18:07:20.000Z - 3 months ago

Omada Health price target raised to $20 from $15 at Evercore ISI

2026-05-08T17:42:02.000Z - 3 months ago

Omada Health price target raised to $26 from $23 at Goldman Sachs

2026-05-08T12:56:22.000Z - 3 months ago

Omada Health price target raised to $24 from $22 at Canaccord

2026-05-08T12:19:40.000Z - 3 months ago

Omada Health price target raised to $18 from $17 at Wells Fargo

2026-05-08T10:15:17.000Z - 3 months ago

Omada Health price target raised to $21 from $18 at Citizens

May 7, 2026, 4:30 PM EDT - 3 months ago

Omada Health Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Omada Health Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Omada Health Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Omada Health Quarterly report: Q1 2026

May 7, 2026, 4:10 PM EDT - 3 months ago

Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support

May 7, 2026, 4:03 PM EDT - 3 months ago

Omada Health Reports First Quarter 2026 Results

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Omada Health Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Omada Health Proxy statement: Proxy filing

Apr 17, 2026, 9:00 AM EDT - 4 months ago

Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds

Apr 16, 2026, 10:19 AM EDT - 4 months ago

Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026

Mar 5, 2026, 4:30 PM EST - 5 months ago

Omada Health Earnings Call Transcript: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Omada Health Annual report: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Omada Health Earnings release: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Omada Health Slides: Q4 2025

Mar 5, 2026, 4:07 PM EST - 5 months ago

Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care

Mar 5, 2026, 4:03 PM EST - 5 months ago

Omada Health Reports Fourth Quarter and Full-Year 2025 Results

Feb 19, 2026, 9:00 AM EST - 6 months ago

Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk

Feb 9, 2026, 9:00 AM EST - 6 months ago

Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026

Jan 14, 2026, 12:00 PM EST - 7 months ago

Omada Health Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:07 AM EST - 7 months ago

Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025

Jan 8, 2026, 9:00 AM EST - 7 months ago

Omada Health's GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss

Dec 22, 2025, 9:00 AM EST - 8 months ago

Omada Health to Participate in J.P. Morgan Healthcare Conference

Dec 3, 2025, 1:20 PM EST - 9 months ago

Omada Health Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 20, 2025, 9:05 AM EST - 9 months ago

Omada Health to Participate in Evercore Healthcare Conference

Nov 18, 2025, 7:19 AM EST - 9 months ago

Omada positioned as a Leader and Emerging Innovator in the SPARK Matrix™: Identity Governance and Administration, 2025 by QKS Group

Nov 7, 2025, 12:47 PM EST - 10 months ago

Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs

Nov 6, 2025, 4:30 PM EST - 10 months ago

Omada Health Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Omada Health Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Omada Health Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Omada Health Slides: Q3 2025

Nov 6, 2025, 4:10 PM EST - 10 months ago

Omada Health Reports Third Quarter 2025 Results

Nov 6, 2025, 4:10 PM EST - 10 months ago

Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population

Nov 6, 2025, 4:05 PM EST - 10 months ago

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows

Nov 4, 2025, 12:00 PM EST - 10 months ago

Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users

Oct 27, 2025, 9:00 AM EDT - 10 months ago

Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer

Oct 16, 2025, 9:01 AM EDT - 10 months ago

Omada Health to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025

Oct 1, 2025, 9:00 AM EDT - 11 months ago

Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting

Sep 9, 2025, 5:35 PM EDT - 1 year ago

Omada Health Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 9:00 AM EDT - 1 year ago

New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions

Aug 28, 2025, 9:00 AM EDT - 1 year ago

New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

Aug 26, 2025, 9:00 AM EDT - 1 year ago

Omada Health to Participate in Upcoming Investor Conference

Aug 7, 2025, 4:47 PM EDT - 1 year ago

Omada Health beats on revenue in first earnings report since IPO

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Omada Health Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Omada Health Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Omada Health Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Omada Health Slides: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 1 year ago

Omada Health Reports Second Quarter 2025 Results

Jul 17, 2025, 4:30 PM EDT - 1 year ago

Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Jun 17, 2025, 9:00 AM EDT - 1 year ago

Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

Jun 6, 2025, 6:13 PM EDT - 1 year ago

Omada Health IPO signals healthier market, avoids ‘down-round' trend

Jun 6, 2025, 4:00 PM EDT - 1 year ago

Diabetes startup Omada Health finally went public after 14 years. Here's who made bank.

Jun 6, 2025, 1:32 PM EDT - 1 year ago

Omada Health IPO: CEO explains why the digital health company went public now

Jun 6, 2025, 11:54 AM EDT - 1 year ago

Digital health company Omada valued at $1.3 billion as shares jump in Nasdaq debut

Jun 6, 2025, 11:49 AM EDT - 1 year ago

Omada shares open at $23 in Nasdaq debut after health-tech company's IPO

Jun 6, 2025, 8:21 AM EDT - 1 year ago

Omada Health IPO to Price at $19 a Share as GLP-1s Fuel Interest

Jun 6, 2025, 7:49 AM EDT - 1 year ago

Omada Health CEO Sean Duffy on IPO debut: Today is the right moment for us

Jun 5, 2025, 8:49 PM EDT - 1 year ago

Omada Health Announces Pricing of Initial Public Offering

Jun 5, 2025, 8:42 PM EDT - 1 year ago

Virtual chronic care provider Omada Health raises $150 million in US IPO

Jun 5, 2025, 8:12 PM EDT - 1 year ago

Omada Health prices IPO at $19 per share, in middle of expected range

Stocktwits Aug. 18 at 8:28 PM

$OMDA Only 440 watchers here 👀

0 · Reply

upsidetrader Aug. 18 at 7:31 PM

$OMDA Monster bull flagpole followed by a bull flag, earnings were excellent. You could do worse. Holding s/t rising moving averages.

0 · Reply

WhatsTheNext10x Aug. 11 at 12:06 PM

0 · Reply

WhatsTheNext10x Aug. 9 at 5:39 AM

0 · Reply

EquityVoyager_1 Aug. 8 at 3:09 PM

0 · Reply

AlphaResearchHQ Aug. 7 at 2:27 PM

0 · Reply

EarningsInsider Aug. 6 at 9:46 PM

https://www.marketbeat.com/earnings/reports/2026-8-6-omada-health-inc-stock/ $OMDA Omada Health Earnings Transcript

0 · Reply

MarketIntel_ Aug. 6 at 9:23 PM

0 · Reply

StocktwitsEarnings Aug. 6 at 8:11 PM

0 · Reply

IN0V8 Aug. 3 at 4:31 PM

$OMDA Barclays raises target price to $25 from $20

0 · Reply

prismmarketview Jul. 22 at 4:33 PM

We are adding #Omadahealth $OMDA to the PRISM Emerging Healthcare Index. Omada runs a virtual between-visit care platform for cardiometabolic conditions, with a GLP-1 Care Track now reaching employers through all three leading pharmacy benefit managers and a new administrator role in Eli Lilly's Employer Connect program. First-quarter revenue rose 42% to $78 million, membership passed one million, and the company turned adjusted EBITDA positive while raising full-year guidance. Omada will host its first investor day in New York on September 10. We will be watching how the GLP-1 wraparound thesis holds up as competition builds. #Healthcare https://prismmarketview.com/companies/omada-health-inc/#abo#O

0 · Reply

MikeCaymanTrades Jun. 30 at 2:52 AM

$OMDA - Trendline up from April 11.19 to 21.37

0 · Reply

StockConsultant Jun. 29 at 2:52 AM

$OMDA Omada Health stock, great breakout at https://stockconsultant.com/?OMDA

0 · Reply

AlphaResearchHQ Jun. 26 at 4:39 PM

$OMDA Pretty happy with this one overall. Got some criticism early on just because it didn’t move right after I bought it. But the thesis has been playing out basically as expected, just slower than people usually tolerate. Now up ~40% in about half a year. Feels like: Price lagged fundamentals at first That delay actually helped build a better position Now the market is finally catching up Not every trade has to be fast to work.

0 · Reply

SuperGreenToday May. 29 at 7:08 PM

$OMDA Share Price: $18.19 Contract Selected: Dec 18, 2026 $20 Calls Buy Zone: $2.72 – $3.36 Target Zone: $5.08 – $6.20 Potential Upside: 76% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

justFrog May. 28 at 3:41 PM

$MAJI this little pink maji has my attention... Gives me a micro $OMDA feel and the bonus of the mail-in cancer screening. Might be worth watching for anyone having fun with Hawkins OTC plays $SPYR $MIXE $GGSM Is the float really 6.6 mil or is the listing drunk? 🧐 https://www.otcmarkets.com/stock/MAJI/security

2 · Reply

zokra244 May. 24 at 9:18 PM

$OMDA Have you tried Shakepay? Sign up with my link and we'll each get $20 to buy crypto: https://shakepay.me/r/1MSA59R Canadian app, buy btc and spend with your cash account to get btc back. !!

0 · Reply

Nalvar14 May. 24 at 9:16 PM

$OMDA 🚀🚀🚀

1 · Reply

R33dh May. 13 at 2:22 PM

$OMDA hmmmm, I like this jump.

0 · Reply

MarketBeat May. 8 at 8:03 PM

Omada Health Q1 Earnings Call Highlights $OMDA #OmadaHealth #instantalerts #NASDAQ:OMDA https://www.marketbeat.com/instant-alerts/omada-hea

0 · Reply

PROTECTORoftheREALM2 May. 8 at 12:15 PM

$OMDA would be nice if we could the 17 level instead of dropping again out of nowhere

1 · Reply

OpenOutcrier May. 8 at 11:57 AM

$OMDA (+3.7% pre) Omada Health (NASDAQ:OMDA) Soars on Q1 Beat, Raised Guidance and Key Partnerships https://ooc.bz/l/101606

0 · Reply

Market Cap	1.45B
Revenue (ttm)	260.21M
Net Income (ttm)	-12.78M
EPS (ttm)	N/A
PE Ratio	300.50
Forward PE	N/A
Profit Margin	-4.91%
Debt to Equity Ratio	0.00

Volume	577,600
Avg Vol	1,340,250
Day's Range	N/A - N/A
Shares Out	61.22M
Stochastic %K	78%
Beta	1.73
Analysts	Strong Sell
Price Target	$27.77